Commission Regulation (EC) No 581/2009 of 3 July 2009 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards gamithromycin (Text with EEA relevance) (c. 581)

ANNEX

In point 1.2.4 of Annex I (List of pharmacologically active substances for which maximum residue limits have been fixed) to Regulation (EEC) No 2377/90 the following entry for ‘Gamithromycin’ is inserted after erythromycin:

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
‘Gamithromycin	Gamithromycin	Bovine	20 μg/kg	Fat	Not for use in animals producing milk for human consumption.’
			200 μg/kg	Liver
			100 μg/kg	Kidney